B
grade
Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial.
Petrelintide · JAMA · 2026Top journal
Not reported in abstract.
Research library
Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.
2468studies indexed1133with human data154registered trials2167carry a numeric findingLibrarian added 0 studies today
Showing 3 studiesSortNewest indexed ▾
D
grade
Petrelintide and the evolving role of amylin agonism in obesity.
Petrelintide · The lancet. Diabetes & endocrinology · 2026Top journal
Not reported in abstract.
A
grade
Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Petrelintide · The lancet. Diabetes & endocrinology · 2026 · RCT · Phase 2Top journal
Petrelintide may lead to significant weight loss in adults with obesity compared to placebo, but further research is needed to confirm its long-term safety and effectiveness.
-9.8% bodyweight change at 28 weeks with petrelintide 5.0 mg vs -1.7% with placebo.
Showing 3 of 3